Get the Stockscreener App
0.0007
89.23%
-0.0058
After Hours:
.04
0.0393
+5,614%
Nascent Biotech Inc Stock (NBIO) Forecast
The Nascent Biotech Inc (NBIO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.293, representing a +41,758% increase from the current price of $0.0007. The highest analyst price target is $0.3114, and the lowest is $0.2747.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NBIO Price Target
Average 0.488
(+69,620% Upside)
Long-term NBIO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Nascent Biotech Inc financial reports and earnings history, Nascent Biotech Inc (NBIO) stock could reach $1.383 by 2030, $4.4601 by 2040 and $4.8316 by 2050. See the projected annual prices until 2050 of the Nascent Biotech Inc stock below:
- Nascent Biotech Inc (NBIO) is expected to reach an average price of $2.6093 in 2035, with a high prediction of $2.8005 and a low estimate of $2.6788. This indicates an $372.66K% rise from the last recorded price of $0.0007.
- Nascent Biotech Inc (NBIO) stock is projected to chart a bullish course in 2040, with an average price target of $4.0798, representing an $582.72K% surge from its current level. The forecast ranges from a conservative $4.1477 to a sky-high $4.4601.
- Our analysts predict Nascent Biotech Inc (NBIO) to jump 815.38K% by 2045, soaring from $3.5869 to an average price of $5.7084, potentially reaching $6.0044. While $3.5869 is the low estimate, the potential upside is significant.
- Nascent Biotech Inc (NBIO) stock is expected to climb by 2050, reaching an average of $4.6376, a $662.41K% jump from its current level. However, a wide range of estimates exists, with high and low targets of $4.8316 and $4.4435, respectively, highlighting the market's uncertainty.
Nascent Biotech Inc Stock (NBIO) Year by Year Forecast
Nascent Biotech Inc Stock (NBIO) Price Forecast for 2025
Nascent Biotech Inc Stock (NBIO) is expected to reach an average price of $0.396 in 2025, with a high prediction of $0.5721 and a low estimate of $0.2199. This indicates an +56,472% rise from the last recorded price of $0.0007.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $0.344 | $0.2747 | $0.3114 | +49,047% |
| July, 2025 | $0.3012 | $0.3357 | $0.3246 | +42,925% |
| August, 2025 | $0.2775 | $0.3045 | $0.2299 | +39,546% |
| September, 2025 | $0.52 | $0.3107 | $0.5721 | +74,181% |
| October, 2025 | $0.4171 | $0.4156 | $0.4446 | +59,480% |
| November, 2025 | $0.3408 | $0.3839 | $0.4382 | +48,580% |
| December, 2025 | $0.4361 | $0.4674 | $0.4221 | +62,198% |
Nascent Biotech Inc Stock (NBIO) Price Forecast for 2026
The predicted value for Nascent Biotech Inc (NBIO) in 2026 is set at an average of $0.6099. Estimates vary from a peak of $0.8308 to a trough of $0.3891, indicating an +87,033% surge from the present price of $0.0007.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.3439 | $0.4315 | $0.4204 | +49,033% |
| February, 2026 | $0.3708 | $0.3891 | $0.3608 | +52,868% |
| March, 2026 | $0.537 | $0.3941 | $0.7014 | +76,617% |
| April, 2026 | $0.5694 | $0.536 | $0.5519 | +81,244% |
| May, 2026 | $0.5678 | $0.4931 | $0.5208 | +81,015% |
| June, 2026 | $0.4882 | $0.5273 | $0.522 | +69,650% |
| July, 2026 | $0.4467 | $0.4737 | $0.4036 | +63,713% |
| August, 2026 | $0.7742 | $0.4709 | $0.8308 | +110.50K% |
| September, 2026 | $0.6534 | $0.6564 | $0.6943 | +93,238% |
| October, 2026 | $0.5592 | $0.6023 | $0.6656 | +79,780% |
| November, 2026 | $0.6321 | $0.6724 | $0.6255 | +90,202% |
| December, 2026 | $0.5221 | $0.6231 | $0.612 | +74,480% |
Nascent Biotech Inc Stock (NBIO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Nascent Biotech Inc (NBIO) is $0.8197, with a high forecast of $1.0894 and a low forecast of $0.5499. This indicates an +116.99K% increase from the last price of $0.0007.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.531 | $0.551 | $0.521 | +75,757% |
| February, 2027 | $0.8386 | $0.5499 | $0.9601 | +119.71K% |
| March, 2027 | $0.7968 | $0.7768 | $0.7823 | +113.72K% |
| April, 2027 | $0.7773 | $0.7115 | $0.7303 | +110.94K% |
| May, 2027 | $0.6753 | $0.7188 | $0.7225 | +96,375% |
| June, 2027 | $0.6159 | $0.6429 | $0.5785 | +87,881% |
| July, 2027 | $1.1112 | $0.6277 | $1.0894 | +158.65K% |
| August, 2027 | $0.8897 | $0.8972 | $1.0284 | +127.00K% |
| September, 2027 | $0.7776 | $0.8207 | $0.8929 | +110.98K% |
| October, 2027 | $0.8505 | $0.8774 | $0.835 | +121.40K% |
| November, 2027 | $0.7002 | $0.8146 | $0.8141 | +99,926% |
| December, 2027 | $0.6912 | $0.7112 | $0.6812 | +98,646% |
Nascent Biotech Inc Stock (NBIO) Price Forecast for 2028
In 2028, Nascent Biotech Inc (NBIO) is projected to reach an average price of $1.0915, with a high projection of $1.4775 and a low estimate of $0.7056. This indicates an +155.83K% rise from the last price of $0.0007.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.0275 | $0.7056 | $1.2188 | +146.69K% |
| February, 2028 | $1.0241 | $1.0176 | $1.0066 | +146.20K% |
| March, 2028 | $0.9867 | $0.9299 | $0.9397 | +140.86K% |
| April, 2028 | $0.8993 | $0.9104 | $0.923 | +128.37K% |
| May, 2028 | $0.785 | $0.812 | $0.8514 | +112.05K% |
| June, 2028 | $1.3699 | $0.7835 | $1.3481 | +195.60K% |
| July, 2028 | $1.126 | $1.138 | $1.2826 | +160.75K% |
| August, 2028 | $0.996 | $1.0391 | $1.1203 | +142.18K% |
| September, 2028 | $1.051 | $1.0823 | $1.0444 | +150.04K% |
| October, 2028 | $0.8783 | $1.0062 | $1.0102 | +125.37K% |
| November, 2028 | $0.8514 | $0.8714 | $0.8414 | +121.54K% |
| December, 2028 | $1.3381 | $0.8614 | $1.4775 | +191.06K% |
Nascent Biotech Inc Stock (NBIO) Price Forecast for 2029
The 2029 price forecast for Nascent Biotech Inc Stock (NBIO) is $1.3377 on average, with a high prediction of $1.7361 and a low estimate of $0.9392. This represents an +191.00K% increase from the previous price of $0.0007.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.2515 | $1.2584 | $1.2728 | +178.68K% |
| February, 2029 | $1.1962 | $1.1483 | $1.1601 | +170.78K% |
| March, 2029 | $1.0908 | $1.1019 | $1.1235 | +155.74K% |
| April, 2029 | $0.9542 | $0.9812 | $1.0385 | +136.22K% |
| May, 2029 | $1.6286 | $0.9392 | $1.6068 | +232.56K% |
| June, 2029 | $1.3708 | $1.3787 | $1.5368 | +195.73K% |
| July, 2029 | $1.2144 | $1.2575 | $1.3476 | +173.38K% |
| August, 2029 | $1.2515 | $1.2873 | $1.2539 | +178.69K% |
| September, 2029 | $1.2095 | $1.1977 | $1.2062 | +172.68K% |
| October, 2029 | $1.0117 | $1.0317 | $1.0114 | +144.42K% |
| November, 2029 | $1.5878 | $1.0171 | $1.7361 | +226.73K% |
| December, 2029 | $1.4788 | $1.4991 | $1.518 | +211.16K% |
Nascent Biotech Inc Stock (NBIO) Price Forecast for 2030
Nascent Biotech Inc Stock (NBIO) is expected to reach an average price of $1.5449 in 2030, with a high forecast of $1.9948 and a low forecast of $1.095. This signifies an +220.60K% surge from the last price of $0.0007.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.4056 | $1.3667 | $1.383 | +200.70K% |
| February, 2030 | $1.2824 | $1.2935 | $1.324 | +183.10K% |
| March, 2030 | $1.0982 | $1.2182 | $1.2256 | +156.78K% |
| April, 2030 | $1.8873 | $1.095 | $1.8655 | +269.51K% |
| May, 2030 | $1.6116 | $1.6195 | $1.791 | +230.13K% |
| June, 2030 | $1.495 | $1.5645 | $1.575 | +213.47K% |
| July, 2030 | $1.452 | $1.4759 | $1.4633 | +207.33K% |
| August, 2030 | $1.3921 | $1.3893 | $1.4022 | +198.77K% |
| September, 2030 | $1.1719 | $1.1919 | $1.185 | +167.31K% |
| October, 2030 | $1.8376 | $1.1729 | $1.9948 | +262.41K% |
| November, 2030 | $1.7415 | $1.7399 | $1.7633 | +248.68K% |
| December, 2030 | $1.6151 | $1.5851 | $1.6887 | +230.62K% |
0.38%
0.02%
Cap:
|
Volume (24h):